Pharma Reports
Each report features BMI's independent 5-year forecasts
Read more
Online Service offering global Country Risk, Financial Markets, Industry and Company Intelligence, Analysis, Data and Forecasts.
Browse and buy BMI's independent reports and research on the pharmaceuticals & healthcare industry.
Browse and buy Espicoms’s independent pharmaceuticals industry reports and research
BMI’s Pharmaceuticals & Healthcare service provides unparalleled analysis and forecasts of market expenditure covering all therapeutic areas, disease prevalence, regulatory and reimbursement policies, and company-by-company activity globally. Our analysts constantly revise and update almost 80 reports and maintain industry forecasts for virtually the entire global pharmaceuticals market. Furthermore, our leading daily news and analysis service critically assesses all major industry developments as they happen.
The service covers all key developments within the following areas: generic drugs, over-the-counter (OTC) medicines, patented drugs, research and development, regulations, biotechnology, medical devices, pricing and reimbursement, imports and exports, supply chain, and epidemiology. At its heart is BMI’s proprietary 10-year Pharmaceutical Expenditure Forecast Model, which incorporates historic trends, macroeconomic variables, epidemiological forecasts and analyst input. A second unique component of the data service is our country-comparative risk-reward Business Environment Rating. This tool facilitates the critical evaluation of opportunities and operational risk in established, emerging and frontier markets, enabling clients to identify and evaluate global industry investment opportunities.
Our analysis is completed by a comprehensive portfolio of company profiles and the Burden of Disease Database (BoDD), an online tool that enables users to forecast the burden of 123 different diseases and injuries across 187 countries, for both genders and in eight age ranges, through to 2030.
BMI’s Pharmaceutical’s service has been strengthened by the acquisition of Espicom, a specialist provider of insight on the global pharmaceutical, generic drug and biosimilar markets. Espicom’s detailed knowledge and report repository of cancer drugs, pipeline developments and therapeutic areas complements BMI’s own country-by-country and company expertise, thereby providing our clients with an integrated, methodologically-robust service that explores, explains and forecasts all major areas of the Pharmaceuticals industry globally.
Business Monitor International (BMI) has published a range of Pharmaceuticals & Healthcare Country reports for professionals doing business in pharmaceuticals and healthcare markets.
Each report features BMI's independent 5-year forecasts for drug and health expenditure, imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.
The regulatory and reimbursements regime, intellectual property rights issues, epidemology, the long-term disease burden and domestic R&D are analysed, as well as the biotech and medical devices sectors. The reports also feature profiles of leading pharmaceuticals companies, covering SWOT analysis, product portfolio, latest financials and key developments.
Browse & Buy Pharma & Healthcare Reports
BMI Special Reports, are a series of ad hoc industry and country reports.
The Country Special Reports focus on key economic events and our key proprietary views which are either global in nature or implication. In contrast Industry Special Reports provide in-depth granular analysis of key industry and market events and issues.
Browse & Buy Pharmaceutical Special Reports
BMI's range of Multinational Pharmaceuticals & Healthcare Companies in Emerging Markets directories contain the latest available, fully researched data on over 99,000 senior executive contacts at over 28,000 leading American, European, Middle-Eastern, African and Asian multinational Pharmaceuticals & Healthcare companies in key emerging markets.
They are a powerful, cost-effective business development and research tool allowing you to immediately source, select and browse with an unlimited facility to export, multinational contacts and Pharmaceuticals & Healthcare companies in emerging markets.
The directories are a must-have marketing tool for all executives conducting business in the emerging markets, providing sales and marketing leads to secure new customers, partners or suppliers. They are ideal for market assessment and planning, as well as benchmarking and analysing your competitors.
Browse & Buy Company Directories
BMI's range of Pharmaceuticals & Healthcare Competitive Intelligence Reports are an essential resource for manufacturers, investors and suppliers analysing and comparing the strategies adopted by major players as they seek to exploit opportunities and mitigate risks in a rapidly changing environment.
BMI assesses the competitive landscape, the market attractiveness for investors and profiles the leading players in Pharmaceuticals & Healthcare in key emerging markets.
Browse & Buy Competitive Intelligence Reports